A current and historical perspective on disparities in US childhood pneumococcal conjugate vaccine adherence and in rates of invasive pneumococcal disease: Considerations for the routinely-recommended, pediatric PCV dosing schedule in the United States

References

• Advisory Committee on Immunization Practices, Preventing pneumococcal disease among infants and young children. Recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm Rep 2000; 49(RR-9):1-35
   Google Scholar
• Black SB, Shinefield HR, Hansen J, Elvin L, Laufer D, Malinoski F. Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2001; 20(12):1105-7; PMID:11740313; http://dx.doi.org/10.1097/00006454-200112000-00002
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease–United States, 1998–2003. MMWR Morb Mortal Wkly Rep 2005; 54(36):893-7; PMID:16163262
   PubMedGoogle Scholar
• Kaplan SL, Mason EO Jr, Wald ER, Schutze GE, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Yogev R, Barson WJ. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 2004; 113(3 Pt 1):443-9; PMID:14993532; http://dx.doi.org/10.1542/peds.113.3.443
   PubMed Web of Science ®Google Scholar
• Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, Lexau CA, Thomas AR, Harrison LH, Reingold AL. et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 2006; 295(14):1668-74; PMID:16609088; http://dx.doi.org/10.1001/jama.295.14.1668
   PubMed Web of Science ®Google Scholar
• Spicer JO, Thomas S, Holst A, Baughman W, Farley MM, et al. Socioeconomic and racial disparities of pediatric invasive pneumococcal disease after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2014; 33(2):158-64; PMID:24418837; http://dx.doi.org/10.1097/INF.0000000000000025
   PubMed Web of Science ®Google Scholar
• Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 2003; 348(18):1737-46; PMID:12724479; http://dx.doi.org/10.1056/NEJMoa022823
   PubMed Web of Science ®Google Scholar
• Wortham JM, Zell ER, Pondo T, Harrison LH, Schaffner W, Lynfield R, Thomas A, Reingold A, Bennett NM, Petit S, et al. Racial disparities in invasive Streptococcus pneumoniae infections, 1998–2009. Clin Infect Dis 2014; 58(9):1250-7; PMID:24585565; http://dx.doi.org/10.1093/cid/ciu108
   PubMed Web of Science ®Google Scholar
• Centers for disease control and prevention active bacterial core surveillance emerging infections program network. ABC Report: Streptococcus Pneumoniae 1997-2012
   Google Scholar
• Hanage WP, Bishop CJ, Huang SS, Stevenson AE, Pelton SI, Lipsitch M, Finkelstein JA. Carried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching. Pediatr Infect Dis J 2011; 30(4):302-8; PMID:21085049; http://dx.doi.org/10.1097/INF.0b013e318201a154
   PubMed Web of Science ®Google Scholar
• Huang SS, Hinrichsen VL, Stevenson AE, Rifas-Shiman SL, Kleinman K, Pelton SI, Lipsitch M, Hanage WP, Lee GM, Finkelstein JA. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009; 124(1):e1-11; PMID:19564254; http://dx.doi.org/10.1542/peds.2008-3099
   PubMed Web of Science ®Google Scholar
• Davidson M, Parkinson AJ, Bulkow LR, Fitzgerald MA, Peters HV, Parks DJ. The epidemiology of invasive pneumococcal disease in Alaska, 1986–1990–ethnic differences and opportunities for prevention. J Infect Dis 1994; 170(2):368-76; PMID:8035023; http://dx.doi.org/10.1093/infdis/170.2.368
   PubMed Web of Science ®Google Scholar
• Hsu KK, Shea KM, Stevenson AE, Pelton SI, Massachusetts Department of Public Health. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001–2007. Pediatr Infect Dis J 2010; 29(4):289-93; PMID:19935447
   PubMed Web of Science ®Google Scholar
• Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, Jackson D, Thomas A, Beall B, Lynfield R, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998–2004. J Infect Dis 2007; 196(9):1346-54; PMID:17922399; http://dx.doi.org/10.1086/521626
   PubMed Web of Science ®Google Scholar
• Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008; 197(7):1016-27; PMID:18419539; http://dx.doi.org/10.1086/528996
   PubMed Web of Science ®Google Scholar
• Jacobs MR, Good CE, Bajaksouzian S, Windau AR. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis 2008; 47(11):1388-95; PMID:18959493; http://dx.doi.org/10.1086/592972
   PubMed Web of Science ®Google Scholar
• Mera R, Miller LA, Fritsche TR, Jones RN. Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine. Microb Drug Resist 2008; 14(2):101-7; PMID:18491947; http://dx.doi.org/10.1089/mdr.2008.0782
   PubMed Web of Science ®Google Scholar
• Byington CL, Samore MH, Stoddard GJ, Barlow S, Daly J, Korgenski K, Firth S, Glover D, Jensen J, Mason EO, et al. Temporal trends of invasive disease due to Streptococcus pneumoniae among children in the intermountain west: emergence of nonvaccine serogroups. Clin Infect Dis 2005; 41(1):21-9; PMID:15937758; http://dx.doi.org/10.1086/430604
   PubMed Web of Science ®Google Scholar
• Huang SS, Platt R, Rifas-Shiman SL, Pelton SI, Goldmann D, Finkelstein JA. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 2005; 116(3):e408-13; PMID:16140686; http://dx.doi.org/10.1542/peds.2004-2338
   PubMedGoogle Scholar
• Rosen JB, Thomas AR, Lexau CA, Reingold A, Hadler JL, Harrison LH, Bennett NM, Schaffner W, Farley MM, Beall BW, et al. Geographic variation in invasive pneumococcal disease following pneumococcal conjugate vaccine introduction in the United States. Clin Infect Dis 2011; 53(2):137-43; PMID:21690620; http://dx.doi.org/10.1093/cid/cir326
   PubMed Web of Science ®Google Scholar
• Nuorti JP, Whitney CG; Centers for Disease Control and Prevention (CDC). Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010; 59(RR-11):1-18; PMID:21150868
   PubMedGoogle Scholar
• Lexau CA, Lynfield R, Danila R, Pilishvili T, Facklam R, Farley MM, Harrison LH, Schaffner W, Reingold A, Bennett NM, et al. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005; 294(16):2043-51; PMID:16249418; http://dx.doi.org/10.1001/jama.294.16.2043
   PubMed Web of Science ®Google Scholar
• Ramani RR, Hall WN, Boulton M, Johnson DR, Zhu BP. Impact of PCV7 on invasive pneumococcal disease among children younger than 5 years: a population-based study. Am J Public Health 2004; 94(6):958-9; PMID:15249298; http://dx.doi.org/10.2105/AJPH.94.6.958
   PubMed Web of Science ®Google Scholar
• Moore MR. Update on effectiveness and impact of PCV13 use among U.S. children, centers for disease control and prevention active bacterial core surveillance emergin infections program network. Editor. February 26, 2014.
   Google Scholar
• Griffin MR, Zhu Y, Moore MR, Whitney CG, Grijalva CG. U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. N Engl J Med 2013; 369(2):155-63; PMID:23841730; http://dx.doi.org/10.1056/NEJMoa1209165
   PubMed Web of Science ®Google Scholar
• Stoecker C, Hampton LM, Link-Gelles R, Messonnier ML, Zhou F, Moore MR. Cost-effectiveness of using 2 vs 3 primary doses of 13-valent pneumococcal conjugate vaccine. Pediatrics 2013; 132(2):e324-32; PMID:23821695; http://dx.doi.org/10.1542/peds.2012-3350
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention, National, state, and local area vaccination coverage among children aged 19–35 months - United States, 2012. MMWR Morb Mortal Wkly Rep 2013; 62(36):733-40; PMID:24025754
   PubMed Web of Science ®Google Scholar
• United Kingdom Health Protection Agency, Quarterly vaccination coverage statistics for children aged up to five years in the UK (COVER programme): January to March 2013. June 2013.
   Google Scholar
• Elam-Evans LD, Yankey D, Singleton JA, Kolasa M; Centers for Disease Control and Prevention (CDC). National, state, and selected local area vaccination coverage among children aged 19–35 months - United States, 2013. MMWR Morb Mortal Wkly Rep 2014; 63(34):741-8; PMID:25166924
   PubMed Web of Science ®Google Scholar
• CDC/NHCS and National Center for Immunization and Respiratory Disease, National immunization survey. Figure depicting coverage with individual vaccines from the inception of NIS, 1994 through 2012. June 2013.
   Google Scholar
• CDC/NHCS and national center for immunization and respiratory disease, Natl Immun Survey August 2014
   Google Scholar
• Flannery B, Schrag S, Bennett NM, Lynfield R, Harrison LH, Reingold A, Cieslak PR, Hadler J, Farley MM, Facklam RR, et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. JAMA 2004; 291(18):2197-203; PMID:15138241; http://dx.doi.org/10.1001/jama.291.18.2197
   PubMed Web of Science ®Google Scholar
• Harrison LH, Dwyer DM, Billmann L, Kolczak MS, Schuchat A. Invasive pneumococcal infection in Baltimore, Md: implications for immunization policy. Arch Intern Med 2000; 160(1):89-94; PMID:10632309; http://dx.doi.org/10.1001/archinte.160.1.89
   PubMedGoogle Scholar
• Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, Kolczak MS, Breiman RF. Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team. N Engl J Med 2000; 342(10):681-9; PMID:10706897; http://dx.doi.org/10.1056/NEJM200003093421002
   PubMed Web of Science ®Google Scholar
• Robinson KA, Baughman W, Rothrock G, Barrett NL, Pass M, Lexau C, Damaske B, Stefonek K, Barnes B, Patterson J, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998: opportunities for prevention in the conjugate vaccine era. JAMA 2001; 285(13):1729-35; PMID:11277827; http://dx.doi.org/10.1001/jama.285.13.1729
   PubMed Web of Science ®Google Scholar
• Soto K, Petit S, Hadler JL, Changing disparities in invasive pneumococcal disease by socioeconomic status and race/ ethnicity in Connecticut, 1998–2008. Public Health Rep 2011; 126 Suppl 3:81-8; PMID:21836741
   PubMed Web of Science ®Google Scholar
• Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Mitchel E, Schaffner W, Craig AS, Edwards KM, Griffin MR. Elimination of racial differences in invasive pneumococcal disease in young children after introduction of the conjugate pneumococcal vaccine. Pediatr Infect Dis J 2004; 23(8):726-31; PMID:15295222; http://dx.doi.org/10.1097/01.inf.0000133046.60555.de
   PubMed Web of Science ®Google Scholar
• Peters TR, Poehling KA. Invasive pneumococcal disease: the target is moving. JAMA 2007; 297(16):1825-6; PMID:17456826; http://dx.doi.org/10.1001/jama.297.16.1825
   PubMed Web of Science ®Google Scholar
• Rudolph KM, Parkinson AJ, Reasonover AL, Bulkow LR, Parks DJ, Butler JC. Serotype distribution and antimicrobial resistance patterns of invasive isolates of Streptococcus pneumoniae: Alaska, 1991–1998. J Infect Dis 2000; 182(2):490-6; PMID:10915080; http://dx.doi.org/10.1086/315716
   PubMed Web of Science ®Google Scholar
• Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, Butler JC, Rudolph K, Parkinson A. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007; 297(16):1784-92; PMID:17456820; http://dx.doi.org/10.1001/jama.297.16.1784
   PubMed Web of Science ®Google Scholar
• Kaplan SL, Barson WJ, Lin PL, Romero JR, Bradley JS, Tan TQ, Hoffman JA, Givner LB, Mason EO Jr. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 2013; 32(3):203-7; PMID:23558320; http://dx.doi.org/10.1097/INF.0b013e318275614b
   PubMed Web of Science ®Google Scholar
• Vernacchio L, Lesko SM, Vezina RM, Corwin MJ, Hunt CE, Hoffman HJ, Mitchell AA. Racial/ethnic disparities in the diagnosis of otitis media in infancy. Int J Pediatr Otorhinolaryngol 2004; 68(6):795-804; PMID:15126021; http://dx.doi.org/10.1016/j.ijporl.2004.01.012
   PubMed Web of Science ®Google Scholar
• Gerber JS, Prasad PA, Localio AR, Fiks AG, Grundmeier RW, Bell LM, Wasserman RC, Rubin DM, Keren R, Zaoutis TE. Racial differences in antibiotic prescribing by primary care pediatricians. Pediatrics 2013; 131(4):677-84; PMID:23509168; http://dx.doi.org/10.1542/peds.2012-2500
   PubMed Web of Science ®Google Scholar
• Pilishvili T, Zell ER, Farley MM, Schaffner W, Lynfield R, Nyquist AC, Vazquez M, Bennett NM, Reingold A, Thomas A, et al. Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use. Pediatrics 2010; 126(1):e9-17; PMID:20547641; http://dx.doi.org/10.1542/peds.2009-2150
   PubMedGoogle Scholar
• U.S. Department of Health and Human Services. Office of Disease Prevention and Health Promotion, Healthy People 2020. Washington, DC. Accessed at http://www.healthypeople.gov/2020/default.aspx. Accessed May 27, 2014.
   Google Scholar
• Hull BP, et al. Immunisation coverage, 2012. Commun Dis Intell Q Rep 2014; 38(3):E208-31; PMID:25391407
   PubMedGoogle Scholar
• De Wals P, Boulianne N, Sévin E, Ouakki M, Deceuninck G, Guay M. Uptake of pneumococcal conjugate vaccine: methodological issues in measurement and impact of publicly funded programs. Can J Public Health 2009; 100(6):413-6; PMID:20209732
   PubMed Web of Science ®Google Scholar
• Ventura SJ, Changing Patterns of Nonmarital Childbearing in the United States. NCHS Data Brief No. 18. May 2009, Accessed at http://www.cdc.gov/nchs/data/databriefs/db18.htm.
   Google Scholar
• Barker L, Luman E, Zhao Z, Smith P, Linkins R, Santoli J, Rodewald L, McCauley M, Centers for Disease Control and Prevention (CDC). National, state, and urban area vaccination coverage levels among children aged 19–35 months–United States, 2001. MMWR Morb Mortal Wkly Rep 2002; 51(30):664-6; PMID:12197212
   PubMedGoogle Scholar
• Luman ET, Barker LE, Simpson DM, Rodewald LE, Szilagyi PG, Zhao Z. National, state and urban-area vaccination-coverage levels among children aged 19–35 months, United States, 1999. Am J Prev Med 2001; 20(4 Suppl):88-153; PMID:12174806
   PubMed Web of Science ®Google Scholar
• Barker LE, Chu SY, Li Q, Shaw KM, Santoli JM. Disparities between white and African-American children in immunization coverage. J Natl Med Assoc 2006; 98(2):130-5; PMID:16708496
   PubMed Web of Science ®Google Scholar
• Strategies to sustain success in childhood immunizations. The National Vaccine Advisory Committee. JAMA 1999; 282(4):363-70; PMID:10432034; http://dx.doi.org/10.1001/jama.282.4.363
   PubMedGoogle Scholar
• Klevens RM, Luman, ET, U.S. children living in and near poverty: risk of vaccine-preventable diseases. Am J Prev Med 2001; 20(4 Suppl):41-6; PMID:11331131; http://dx.doi.org/10.1016/S0749-3797(01)00281-1
   PubMed Web of Science ®Google Scholar
• Orenstein WA, Atkinson W, Mason D, Bernier RH. Barriers to vaccinating preschool children. J Health Care Poor Underserved 1990; 1(3):315-30; PMID:2130911; http://dx.doi.org/10.1353/hpu.2010.0324
   PubMedGoogle Scholar
• Kenyon TA, Matuck MA, Stroh G, Persistent low immunization coverage among inner-city preschool children despite access to free vaccine. Pediatrics 1998; 101(4 Pt 1):612-6; PMID:9521942; http://dx.doi.org/10.1542/peds.101.4.612
   PubMed Web of Science ®Google Scholar
• Bates AS, Fitzgerald JF, Dittus RS, Wolinsky, FD. Risk factors for underimmunization in poor urban infants. JAMA 1994; 272(14):1105-10; PMID:7933322; http://dx.doi.org/10.1001/jama.1994.03520140035034
   PubMed Web of Science ®Google Scholar
• Daniels D, Jiles RB, Klevens RM, Herrera GA. Undervaccinated African-American preschoolers: a case of missed opportunities. Am J Prev Med 2001; 20(4 Suppl):61-8; PMID:11331134; http://dx.doi.org/10.1016/S0749-3797(01)00278-1
   PubMed Web of Science ®Google Scholar
• Herrera GA, Zhao Z, Klevens RM. Variation in vaccination coverage among children of Hispanic ancestry. Am J Prev Med 2001; 20(4 Suppl):69-74; PMID:11331135; http://dx.doi.org/10.1016/S0749-3797(01)00277-X
   PubMed Web of Science ®Google Scholar
• Wood D, Donald-Sherbourne C, Halfon N, Tucker MB, Ortiz V, Hamlin JS, Duan N, Mazel RM, Grabowsky M, Brunell P, et al. Factors related to immunization status among inner-city Latino and African-American preschoolers. Pediatrics 1995; 96(2 Pt 1):295-301; PMID:7630688
   PubMed Web of Science ®Google Scholar
• Zhao Z, Smith PJ. Trends in vaccination coverage disparities among children, United States, 2001–2010. Vaccine 2013; 31(19):2324-7; PMID:23524025; http://dx.doi.org/10.1016/j.vaccine.2013.03.018
   PubMed Web of Science ®Google Scholar
• Zhao Z, Luman ET. Progress toward eliminating disparities in vaccination coverage among U.S. children, 2000–2008. Am J Prev Med 2010; 38(2):127-37; PMID:20117568; http://dx.doi.org/10.1016/j.amepre.2009.10.035
   PubMed Web of Science ®Google Scholar
• Fairbrother G, Friedman S, DuMont KA, Lobach KS. Markers for primary care: missed opportunities to immunize and screen for lead and tuberculosis by private physicians serving large numbers of inner-city Medicaid-eligible children. Pediatrics 1996; 97(6 Pt 1):785-90; PMID:8657515
   PubMed Web of Science ®Google Scholar
• Goldstein KP, Lauderdale DS, Glushak C, Walter, J, Daum, RS. Immunization outreach in an inner-city housing development: reminder-recall on foot. Pediatrics 1999; 104(6):e69; PMID:10586003; http://dx.doi.org/10.1542/peds.104.6.e69
   PubMedGoogle Scholar
• U.S. General Accounting Office, CDC's National Immunization Program: methods used to identify pockets of underimmunized children not evaluated (GAO/HEHS-97-136R). Aug 1, 1997.
   Google Scholar
• Santoli JM, Setia S, Rodewald LE, O'Mara D, Gallo B, Brink E. Immunization pockets of need: science and practice. Am J Prev Med 2000; 19(3 Suppl):89-98; PMID:11024333; http://dx.doi.org/10.1016/S0749-3797(00)00209-9
   PubMed Web of Science ®Google Scholar
• Bottino CJ, Cox JE, Kahlon PS, Samuels RC. Improving immunization rates in a hospital-based primary care practice. Pediatrics 2014; 133(4):e1047-54; PMID:24664096; http://dx.doi.org/10.1542/peds.2013-2494
   PubMed Web of Science ®Google Scholar
• Suryadevara M, Bonville CA, Ferraioli F, Domachowske JB. Community-centered education improves vaccination rates in children from low-income households. Pediatrics 2013; 132(2):319-25; PMID:23837177; http://dx.doi.org/10.1542/peds.2012-3927
   PubMed Web of Science ®Google Scholar
• Dubé E, Gagnon D, Nickels E, Jeram S, Schuster M. Mapping vaccine hesitancy–country-specific characteristics of a global phenomenon. Vaccine 2014; 32(49):6649-54; PMID:25280436; http://dx.doi.org/10.1016/j.vaccine.2014.09.039
   PubMed Web of Science ®Google Scholar
• Dube E, Vivion M, MacDonald NE. Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications. Expert Rev Vaccines 2015; 14(1):99-117; PMID:25373435; http://dx.doi.org/10.1586/14760584.2015.964212
   PubMed Web of Science ®Google Scholar
• Larson HJ, Jarrett C, Eckersberger E, Smith DM, Paterson P. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine 2014; 32(19):2150-9; PMID:24598724; http://dx.doi.org/10.1016/j.vaccine.2014.01.081
   PubMed Web of Science ®Google Scholar
• Siddiqui M, Salmon DA, Omer SB. Epidemiology of vaccine hesitancy in the United States. Hum Vaccin Immunother 2013; 9(12):2643-8; PMID:24247148; http://dx.doi.org/10.4161/hv.27243
   PubMed Web of Science ®Google Scholar
• Hendrix KS, Finnell SM, Zimet GD, Sturm LA, Lane KA, Downs SM. Vaccine Message Framing and Parents' Intent to Immunize Their Infants for MMR. Pediatrics 2014; 134(3):e675-83; PMID:25136038; http://dx.doi.org/10.1542/peds.2013-4077
   PubMed Web of Science ®Google Scholar
• Ray GT, Pelton SI, Klugman KP, Strutton DR, Moore MR. Cost-effectiveness of pneumococcal conjugate vaccine: an update after 7 years of use in the United States. Vaccine 2009; 27(47):6483-94; PMID:19720366; http://dx.doi.org/10.1016/j.vaccine.2009.08.045
   PubMed Web of Science ®Google Scholar
• Rubin JL, McGarry LJ, Strutton DR, Klugman KP, Pelton SI, Gilmore KE, Weinstein MC. Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States. Vaccine 2010; 28(48):7634-43; PMID:20883739; http://dx.doi.org/10.1016/j.vaccine.2010.09.049
   PubMed Web of Science ®Google Scholar
• Chatterjee A, O'Keefe C. Current controversies in the USA regarding vaccine safety. Expert Rev Vaccines 2010; 9(5):497-502; PMID:20450324; http://dx.doi.org/10.1586/erv.10.36
   PubMed Web of Science ®Google Scholar
• Majumder MS, Cohn EL, Mekaru SR, Huston JE, Brownstein JS. Substandard vaccination compliance and the 2015 measles outbreak. JAMA Pediatr 2015; 169(5):494-5; PMID:25774618; http://dx.doi.org/10.1001/jamapediatrics.2015.0384
   PubMed Web of Science ®Google Scholar
• Andrews NJ, Waight PA, Burbidge P, Pearce E, Roalfe L, Zancolli M, Slack M, Ladhani SN, Miller E, Goldblatt D. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study. Lancet Infect Dis 2014; 14(9):839-46; PMID:25042756; http://dx.doi.org/10.1016/S1473-3099(14)70822-9
   PubMed Web of Science ®Google Scholar